Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment. Tanzania Medical Journal, [S. l.], v. 31, n. 3, p. 1–14, 2020. DOI: 10.4314/tmj.v31i3.359. Disponível em: https://www.tmj.or.tz/index.php/tmj/article/view/359.. Acesso em: 14 may. 2025.